Keywords
alveolar hemorrhage
mortality
How to Cite
Abstract
Introduction: Introduction: Diffuse alveolar hemorrhage (DAH) is a rare and potentially fatal manifestation of systemic lupus erythematosus (SLE).
Objective: to present the clinical characteristics, treatment and mortality of two patients with diffuse alveolar hemorrhage as the initial manifestation of SLE.
Materials and Methods: case series of two patients with diffuse alveolar hemorrhage as the initial manifestation of SLE, hospitalized in the Department of Internal Medicine of the National Hospital of Itaugua between 2007-2018.
Results: of 500 patients with SLE, 2 women (0,4%) presented with alveolar hemorrhage as the initial manifestation of disease. The average age was 22 years, and average disease duration was 60 ± 42,4 days. All patients presented dyspnea, fever, hemoptysis, decrease in Hb, bilateral pulmonary infiltrates on chest X-ray, nephritis, and acute respiratory failure with mechanical ventilation (ARM) requirement. One of the two patients had renal failure. Both patients were treated with intravenous pulses of methylprednisolone (1g for 3 days) and cyclophosphamide. One patient required hemodialysis. One patient had a kidney biopsy which confirmed a class III/C nephritis. One patient had good response to treatment and one patient died.
Comment: Both patients presented with DAH, associated nephropathy and need for mechanical ventilation. Death occurred in the patient with nephropathy and acute renal failure.
References
(1) Hannah JR, D‘Cruz DP. Pulmonary Complications of Systemic Lupus Erythematosus. Semin Respir Crit Care Med. 2019;40(2):227-234. doi: 10.1055/s-0039-1685537
(2) Zamora MR, Warner ML, Tuder R, Schwarz Mi. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine. 1997;76(3):192- 202.
(3) Kim D, Choi J, Cho SK, Choi CB, Kim TH, Jun JB, et al . Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rhe um. 2017;46(6):782-787.
(4) Andrade C, Mendonça T, Farinha F, Correia J, Marinho A, Almeida i, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus. 2016;25(1):75-80.
(5) Ednalino C, Yip J, Carsons SE. Systematic Review of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: Focus on Outcome and Therapy. J Clin Rheumatol. 2015;21(6):305-10.
(6) Martínez-MartínezMu, Abud-Mendoza C. Diffuse alveolar he- morrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis. Reumatol Clin. 2014;10(4):248-53. doi: 10.1016/j.reuma.2014.02.002
(7) Luna G, Chauveau D, Aniort J, Carron PL, Gobert P, Karras A, et al. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French vasculitis Study Group. J Autoimmun. 2015;65:49-55.
(8) Walsh M, Merkel PA, Jayne D. The effects of plasma exchangeand reduced-dose glucocorticoids during remission-induction for treat- ment of severe ANCA-associated vasculitis. Arthritis Rheum. 2018;70(Suppl 10):2788.
(9) Chang MY, Fang JT, Chen YC, Huang CC. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren Fail. 2002;24(6):791-802.
(10) Wang CR, Liu MF, Weng CT, Lin WC, Li WT, Tsai HW. Systemic lupus erythematosus-associated diffuse alveolar haemorrhage: a single-centre experience in Han Chinese patients. Scand J Rheumatol. 2018;47(5):392-399.
(11) Kwok SK, Moon SJ, Ju JH, Park KS, Kim Wu, Cho CS, et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus. 2011;20(1):102-7. doi: 10.1177/0961203310381511
(12) Shen M, Zeng xJ, Fan HW, xu WB, Zhang FC. Diffuse alveolar hemorrhage in systemic lupus erythematosus Zhonghua Yi xue Za Zhi. 2009;89(3):201-3.
(13) Hansen T, Brockmann H, Gaumann A, Mayet W, Schwarting A, Galle PR, et al. Fulminant course of diffuse alveolar hemorrhage in systemic lupus erythematosus--a case report. Z Rheumatol. 2002;61(2):175-9.
(14) Finucci Curi P, Pierrestegui M, Ortiz A, Ceccato F, Paira S. Hemorragia pulmonar en pacientes con lupus eritematoso sistémico. Características clínicas, pronóstico y revisión de la bibliografía. Disponible en: http://dx.doi.org/10.1016/j.medcli.2014.07.034
(15) Zamarrón E, Barandica D, Fernández-Bujarrabal J, Martínez Abad Y. Síndrome de hemorragia alveolar difusa. Medicine. 2018;12(67):3941-8 3941.